Advanced search
Publication Cover
Future Cardiology Volume 7, 2011 - Issue 2
Submit an article Journal homepage
126
Views
0
CrossRef citations to date
0
Altmetric
Review

Treatment of Congenital Heart Disease: risk-reducing Measures in Young Adults

Teun van der Bom1 Department of Cardiology Academic Medical CenterAmsterdamThe Netherlands.;2 Interuniversity Cardiology Institute of The NetherlandsUtrechtThe Netherlands
,
Paul Luijendijk1 Department of Cardiology Academic Medical CenterAmsterdamThe Netherlands.;2 Interuniversity Cardiology Institute of The NetherlandsUtrechtThe Netherlands
,
Berto J Bouma1 Department of Cardiology Academic Medical CenterAmsterdamThe Netherlands.
,
Dave R Koolbergen3 Department of Cardio-thoracic Surgery Academic Medical CenterAmsterdamThe Netherlands
,
Joris R de Groot1 Department of Cardiology Academic Medical CenterAmsterdamThe Netherlands.
&
Barbara JM Mulder1 Department of Cardiology Academic Medical CenterAmsterdamThe Netherlands.;2 Interuniversity Cardiology Institute of The NetherlandsUtrechtThe NetherlandsCorrespondence[email protected]
Pages 227-240 | Published online: 31 Mar 2011

Bibliography

  • Khairy P , Ionescu-IttuR, MackieASet al.: Changing mortality in congenital heart disease.J. Am. Coll. Cardiol., 56(14), 1149–1157 (2010).
  • Marelli AJ , MackieAS, Ionescu-IttuR, RahmeE, PiloteL: Congenital heart disease in the general population: changing prevalence and age distribution.Circulation, 115(2), 163–172 (2007).
  • Engelfriet P , BoersmaE, OechslinEet al.: The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease.Eur. Heart J., 26(21), 2325–2333 (2005).
  • Warnes CA : The adult with congenital heart disease: born to be bad?J. Am. Coll. Cardiol., 46(1), 1–8 (2005).
  • Oechslin EN , HarrisonDA, ConnellyMS, WebbGD, SiuSC: Mode of death in adults with congenital heart disease.Am. J. Cardiol., 86(10), 1111–1116 (2000).
  • Pillutla P , ShettyKD, FosterE: Mortality associated with adult congenital heart disease: trends in the US population from 1979 to 2005.Am. Heart J., 158(5), 874–879 (2009).
  • Zomer AC , UiterwaalCSPMet al., der Velde ETV : Mortality in adult congenital heart disease: are national registries reliable for cause of death? Int. J. Cardiol. (2010) (Epub ahead of print).
  • Baumgartner H , BonhoefferPet al., De Groot NMS : ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): the Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC). Eur. Heart J., 31(23), 2915–2957 (2010).
  • Warnes CA , WilliamsRG, BashoreTMet al.: ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.J. Am. Coll. Cardiol., 52(23), e1–e121 (2008).
  • Piran S , VeldtmanG, SiuS, WebbGD, LiuPP: Heart failure and ventricular dysfunction in patients with single or systemic right ventricles.Circulation, 105(10), 1189–1194 (2002).
  • McKee PA , CastelliWP, McNamaraPM, KannelWB: The natural history of congestive heart failure: the Framingham study.N. Engl. J. Med., 285(26), 1441–1446 (1971).
  • Verheugt CL , UiterwaalCSPMet al., van der Velde ET : Mortality in adult congenital heart disease. Eur. Heart J., 31(10), 1220–1229 (2010).
  • Warnes CA : Adult congenital heart disease importance of the right ventricle.J. Am. Coll. Cardiol., 54(21), 1903–1910 (2009).
  • Ikeda U , FuruseM, SuzukiOet al.: Long-term survival in aged patients with corrected transposition of the great arteries.Chest, 101(5), 1382–1385 (1992).
  • Pézard P , BanusY, LaporteJet al.: Corrected transposition of the great vessels in aged adults. Apropos of 2 patients aged 72 and 80.Arch. Mal Coeur Vaiss., 79(11), 1637–1642 (1986).
  • Book W : Heart failure in the adult patient with congenital heart disease.J. Card. Fail., 11(4), 306–312 (2005).
  • Bolger AP , SharmaR, LiWet al.: Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease.Circulation, 106(1), 92–99 (2002).
  • Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N. Engl. J. Med., 325(5), 293–302 (1991).
  • Pfeffer MA , SwedbergK, GrangerCBet al.: Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.Lancet, 362(9386), 759–766 (2003).
  • Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet, 353(9169), 2001–2007 (1999).
  • Brophy JM , JosephL, RouleauJL: β-blockers in congestive heart failure. A Bayesian meta-analysis.Ann. Intern. Med., 134(7), 550–560 (2001).
  • Winter MM et al. , van der Plas MN, Bouma BJ : Mechanisms for cardiac output augmentation in patients with a systemic right ventricle. Int. J. Cardiol., 143(2), 141–146 (2009).
  • Uebing A , DillerG, LiWet al.: Optimized rate-responsive pacing does not improve either right ventricular hemodynamics or exercise capacity in adults with a systemic right ventricle.Cardiol. Young, 20(5), 485–494 (2010).
  • Haddad F , DoyleR, MurphyDJ, HuntSA: Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure.Circulation, 117(13), 1717–1731 (2008).
  • Winter MM , BoumaBJ, GroeninkMet al.: Latest insights in therapeutic options for systemic right ventricular failure: a comparison with left ventricular failure.Heart, 95(12), 960–963 (2009).
  • Dore A , HoudeC, ChanKet al.: Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a multicenter, randomized, placebo-controlled clinical trial.Circulation, 112(16), 2411–2416 (2005).
  • van der Bom T , WinterMM, BoumaBJet al.: Rationale and design of a trial on the effect of angiotensin II receptor blockers on the function of the systemic right ventricle.Am. Heart J., 160(5), 812–818 (2010).
  • Schuuring MJ , VisJC, DuffelsMG, BoumaBJ, MulderBJ: Adult patients with pulmonary arterial hypertension due to congenital heart disease: a review on advanced medical treatment with bosentan.Ther. Clin. Risk Manag., 6, 359–366 (2010).
  • Beghetti M : Fontan and the pulmonary circulation: a potential role for new pulmonary hypertension therapies.Heart, 96(12), 911–916 (2010).
  • Ishibashi N , ParkI, TakahashiYet al.: Effectiveness of carvedilol for congestive heart failure that developed long after modified Fontan operation.Pediatr. Cardiol., 27(4), 473–475 (2006).
  • Kouatli AA , GarciaJA, ZellersTM, WeinsteinEM, MahonyL: Enalapril does not enhance exercise capacity in patients after Fontan procedure.Circulation, 96(5), 1507–1512 (1997).
  • Hsu DT , ZakV, MahonyLet al.: Enalapril in infants with single ventricle: results of a multicenter randomized trial.Circulation, 122(4), 333–340 (2010).
  • Haddad F , AshleyE, MichelakisED: New insights for the diagnosis and management of right ventricular failure, from molecular imaging to targeted right ventricular therapy.Curr. Opin. Cardiol., 25(2), 131–140 (2010).
  • Nagendran J , ArcherSL, SolimanDet al.: Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility.Circulation, 116(3), 238–248 (2007).
  • Michelakis E , TymchakW, LienDet al.: Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide.Circulation, 105(20), 2398–2403 (2002).
  • Graham EM , BandisodeVM, BradleySMet al.: Effect of preoperative use of propranolol on postoperative outcome in patients with tetralogy of Fallot.Am. J. Cardiol., 101(5), 693–695 (2008).
  • Norozi K , BahlmannJ, RaabBet al.: A prospective, randomized, double-blind, placebo controlled trial of β-blockade in patients who have undergone surgical correction of tetralogy of Fallot.Cardiol. Young, 17(4), 372–379 (2007).
  • Cleland JGF , DaubertJ, ErdmannEet al.: The effect of cardiac resynchronization on morbidity and mortality in heart failure.N. Engl. J. Med., 352(15), 1539–1549 (2005).
  • Janousek J : Cardiac resynchronization in congenital heart disease.Heart, 95(11), 940–947 (2009).
  • Cecchin F , FranginiPA, BrownDWet al.: Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution.J. Cardiovasc. Electrophysiol., 20(1), 58–65 (2009).
  • Dubin AM , JanousekJ, RheeEet al.: Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study.J. Am. Coll. Cardiol., 46(12), 2277–2283 (2005).
  • Khairy P : EP challenges in adult congenital heart disease.Heart Rhythm., 5(10), 1464–1472 (2008).
  • Moss AJ , HallWJ, CannomDSet al.: Cardiac-resynchronization therapy for the prevention of heart-failure events.N. Engl. J. Med., 361(14), 1329–1338 (2009).
  • Oosterhof T et al. , van Straten A, Vliegen HW : Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation, 116(5), 545–551 (2007).
  • Therrien J , SiuSC, McLaughlinPRet al.: Pulmonary valve replacement in adults late after repair of tetralogy of fallot: are we operating too late?J. Am. Coll. Cardiol., 36(5), 1670–1675 (2000).
  • Oosterhof T , MeijboomFJ, VliegenHWet al.: Long-term follow-up of homograft function after pulmonary valve replacement in patients with tetralogy of Fallot.Eur. Heart J., 27(12), 1478–1484 (2006).
  • Bouzas B , KilnerPJ, GatzoulisMA: Pulmonary regurgitation: not a benign lesion.Eur. Heart J., 26(5), 433–439 (2005).
  • Vliegen HW et al. , van Straten A, de Roos A : Magnetic resonance imaging to assess the hemodynamic effects of pulmonary valve replacement in adults late after repair of tetralogy of Fallot. Circulation, 106(13), 1703–1707 (2002).
  • Mulder BJM , de Winter RJ, Wilde AAM: Percutaneous pulmonary valve replacement: a new development in the lifetime strategy for patients with congenital heart disease. Neth. Heart J., 15(1), 3–4 (2007).
  • Oosterhof T , HazekampMG, MulderBJM: Opportunities in pulmonary valve replacement.Expert Rev. Cardiovasc. Ther., 7(9), 1117–1122 (2009).
  • Bonhoeffer P , BoudjemlineY, SalibaZet al.: Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction.Lancet, 356(9239), 1403–1405 (2000).
  • Lurz P , GaudinR, TaylorAM, BonhoefferP: Percutaneous pulmonary valve implantation.Semin. Thorac. Cardiovasc. Surg. Pediatr. Card. Surg. Annu., 12, 112–117 (2009).
  • Lurz P , CoatsL, KhambadkoneSet al.: Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome.Circulation, 117(15), 1964–1972 (2008).
  • Romeih S , KroftLJ, BokenkampRet al.: Delayed improvement of right ventricular diastolic function and regression of right ventricular mass after percutaneous pulmonary valve implantation in patients with congenital heart disease.Am. Heart J., 158(1), 40–46 (2009).
  • Koyak Z , de Groot JR, Mulder BJ: Interventional and surgical treatment of cardiac arrhythmias in adults with congenital heart disease. Expert Rev. Cardiovasc. Ther., 8(12), 1753–1766 (2010).
  • de Groot NMS , AtaryJZ, BlomNA, SchalijMJ: Long-term outcome after ablative therapy of postoperative atrial tachyarrhythmia in patients with congenital heart disease and characteristics of atrial tachyarrhythmia recurrences.Circ. Arrhythm Electrophysiol., 3(2), 148–154 (2010).
  • Thorne SA , BarnesI, CullinanP, SomervilleJ: Amiodarone-associated thyroid dysfunction: risk factors in adults with congenital heart disease.Circulation, 100(2), 149–154 (1999).
  • Dobrev D , NattelS: New antiarrhythmic drugs for treatment of atrial fibrillation.Lancet, 375(9721), 1212–1223 (2010).
  • Khairy P , AboulhosnJ, GurvitzMZet al.: Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study.Circulation, 122(9), 868–875 (2010).
  • Kiesewetter C , MichaelK, MorganJ, VeldtmanGR: Left ventricular dysfunction after cardiac resynchronization therapy in congenital heart disease patients with a failing systemic right ventricle.Pacing Clin. Electrophysiol., 31(2), 159–162 (2008).
  • Bardy GH , SmithWM, HoodMAet al.: An entirely subcutaneous implantable cardioverter–defibrillator.N. Engl. J. Med., 363(1), 36–44 (2010).
  • Dave AS , AboulhosnJ, ChildJS, ShivkumarK: Transconduit puncture for catheter ablation of atrial tachycardia in a patient with extracardiac Fontan palliation.Heart Rhythm., 7(3), 413–416 (2010).
  • Khairy P , FournierA, RuestP, VobeckySJ: Transcatheter ablation via a sternotomy approach as a hybrid procedure in a univentricular heart.Pacing Clin. Electrophysiol., 31(5), 639–640 (2008).
  • Biviano A , GaranH, HickeyKet al.: Atrial flutter catheter ablation in adult patients with repaired tetralogy of Fallot: mechanisms and outcomes of percutaneous catheter ablation in a consecutive series.J. Interv. Card. Electrophysiol., 28(2), 125–135 (2010).
  • Cappato R , SchlüterM, WeissCet al.: Radiofrequency current catheter ablation of accessory atrioventricular pathways in Ebstein‘s anomaly.Circulation, 94(3), 376–383 (1996).
  • Hoffmann A , ChockalingamP, BalintOHet al.: Cerebrovascular accidents in adult patients with congenital heart disease.Heart, 96(15), 1223–1226 (2010).
  • Perloff JK , RosoveMH, ChildJS, WrightGB: Adults with cyanotic congenital heart disease: hematologic management.Ann. Intern. Med., 109(5), 406–413 (1988).
  • Thanassoulis G , YipJWL, FilionKet al.: Retrospective study to identify predictors of the presence and rapid progression of aortic dilatation in patients with bicuspid aortic valves.Nat. Clin. Pract. Cardiovasc. Med., 5(12), 821–828 (2008).
  • Vriend JWJ , MulderBJM: Late complications in patients after repair of aortic coarctation: implications for management.Int. J. Cardiol., 101(3), 399–406 (2005).
  • Vriend JWJ et al. , van Montfrans GA, Romkes HH : Relation between exercise-induced hypertension and sustained hypertension in adult patients after successful repair of aortic coarctation. J. Hypertens., 22(3), 501–509 (2004).
  • Clarkson PM , NicholsonMR, Barratt-BoyesBG, NeutzeJM, WhitlockRM: Results after repair of coarctation of the aorta beyond infancy: a 10 to 28 year follow-up with particular reference to late systemic hypertension.Am. J. Cardiol., 51(9), 1481–1488 (1983).
  • O‘Sullivan JJ , DerrickG, DarnellR: Prevalence of hypertension in children after early repair of coarctation of the aorta: a cohort study using casual and 24 hour blood pressure measurement.Heart, 88(2), 163–166 (2002).
  • Beekman RH , KatzBP, Moorehead-SteffensC, RocchiniAP: Altered baroreceptor function in children with systolic hypertension after coarctation repair.Am. J. Cardiol., 52(1), 112–117 (1983).
  • Polson JW , McCallionN, WakiHet al.: Evidence for cardiovascular autonomic dysfunction in neonates with coarctation of the aorta.Circulation, 113(24), 2844–2850 (2006).
  • Gibbons GH , DzauVJ: The emerging concept of vascular remodeling.N. Engl. J. Med., 330(20), 1431–1438 (1994).
  • Therrien J , WebbG: Clinical update on adults with congenital heart disease.Lancet, 362(9392), 1305–1313 (2003).
  • Niwa K , SiuSC, WebbGD, GatzoulisMA: Progressive aortic root dilatation in adults late after repair of tetralogy of Fallot.Circulation, 106(11), 1374–1378 (2002).
  • Dodds GA , WarnesCA, DanielsonGK: Aortic valve replacement after repair of pulmonary atresia and ventricular septal defect or tetralogy of Fallot.J. Thorac. Cardiovasc. Surg., 113(4), 736–741 (1997).
  • Niwa K , PerloffJK, BhutaSMet al.: Structural abnormalities of great arterial walls in congenital heart disease: light and electron microscopic analyses.Circulation, 103(3), 393–400 (2001).
  • Tan JL , DavlourosPA, McCarthyKP, GatzoulisMA, HoSY: Intrinsic histological abnormalities of aortic root and ascending aorta in tetralogy of Fallot: evidence of causative mechanism for aortic dilatation and aortopathy.Circulation, 112(7), 961–968 (2005).
  • Cañadas V , VilacostaI, BrunaI, FusterV: Marfan syndrome. Part 1: pathophysiology and diagnosis.Nat. Rev. Cardiol., 7(5), 256–265 (2010).
  • Engelfriet P , MulderB: Is there benefit of β-blocking agents in the treatment of patients with the Marfan syndrome?Int. J. Cardiol., 114(3), 300–302 (2007).
  • Gersony DR , McClaughlinMA, JinZ, GersonyWM: The effect of β-blocker therapy on clinical outcome in patients with Marfan‘s syndrome: a meta-analysis.Int. J. Cardiol., 114(3), 303–308 (2007).
  • Williams A , DaviesS, StuartAG, WilsonDG, FraserAG: Medical treatment of Marfan syndrome: a time for change.Heart, 94(4), 414–421 (2008).
  • Habashi JP , JudgeDP, HolmTMet al.: Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.Science, 312(5770), 117–121 (2006).
  • Jiménez SA , RosenbloomJ: Angiotensin II blockade in Marfan‘s syndrome.N. Engl. J. Med., 359(16), 1732–1733; author reply 1733–1734 (2008).
  • Xiong W , KnispelRA, DietzHC, RamirezF, BaxterBT: Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome.J. Vasc. Surg., 47(1), 166–172; discussion 172 (2008).
  • Lindeman JHN , AshcroftBA, BeenakkerJMet al.: Distinct defects in collagen microarchitecture underlie vessel-wall failure in advanced abdominal aneurysms and aneurysms in Marfan syndrome.Proc. Natl Acad. Sci. USA, 107(2), 862–865 (2010).
  • Vriend JWJ et al. , de Groot E, de Waal TT : Increased carotid and femoral intima-media thickness in patients after repair of aortic coarctation: influence of early repair. Am. Heart J., 151(1), 242–247 (2006).
  • Tanous D , BensonLN, HorlickEM: Coarctation of the aorta: evaluation and management.Curr. Opin. Cardiol., 24(6), 509–515 (2009).
  • Pedra CAC , FontesVF, EstevesCAet al.: Stenting vs. balloon angioplasty for discrete unoperated coarctation of the aorta in adolescents and adults.Catheter Cardiovasc. Interv., 64(4), 495–506 (2005).
  • Kenny D , MargeyR, TurnerMSet al.: Self-expanding and balloon expandable covered stents in the treatment of aortic coarctation with or without aneurysm formation.Catheter Cardiovasc. Interv., 72(1), 65–71 (2008).
  • Tzifa A , EwertP, Brzezinska-RajszysGet al.: Covered Cheatham-platinum stents for aortic coarctation: early and intermediate-term results.J. Am. Coll. Cardiol., 47(7), 1457–1463 (2006).
  • Svensson LG , KouchoukosNT, MillerDCet al.: Expert consensus document on the treatment of descending thoracic aortic disease using endovascular stent-grafts.Ann. Thorac. Surg., 85(Suppl. 1), S1–S41 (2008).
  • Botta L , RussoVet al., La Palombara C : Stent graft repair of descending aortic dissection in patients with Marfan syndrome: an effective alternative to open reoperation? J. Thorac. Cardiovasc. Surg., 138(5), 1108–1114 (2009).
  • Nordon IM , HinchliffeRJ, HoltPJet al.: Endovascular management of chronic aortic dissection in patients with Marfan syndrome.J. Vasc. Surg., 50(5), 987–991 (2009).
  • David TE , ArmstrongS, MagantiM, ColmanJ, BradleyTJ: Long-term results of aortic valve-sparing operations in patients with Marfan syndrome.J. Thorac. Cardiovasc. Surg., 138(4), 859–864; discussion 863–864 (2009).
  • Emery RW , EricksonCA, AromKVet al.: Replacement of the aortic valve in patients under 50 years of age: long-term follow-up of the St. Jude Medical prosthesis.Ann. Thorac. Surg., 75(6), 1815–1819 (2003).
  • Patel ND , WeissES, AlejoDEet al.: Aortic root operations for Marfan syndrome: a comparison of the Bentall and valve-sparing procedures.Ann. Thorac. Surg., 85(6), 2003–2010; discussion 2010–2011 (2008).
  • David TE , FeindelCM, WebbGDet al.: Aortic valve preservation in patients with aortic root aneurysm: results of the reimplantation technique.Ann. Thorac. Surg., 83(2), S732–735; discussion S785–S790 (2007).
  • Cameron DE , AlejoDE, PatelNDet al.: Aortic root replacement in 372 Marfan patients: evolution of operative repair over 30 years.Ann. Thorac. Surg., 87(5), 1344–1349; discussion 1349–1350 (2009).
  • de Kerchove L , BoodhwaniM, EtiennePet al.: Preservation of the pulmonary autograft after failure of the Ross procedure.Eur. J. Cardiothorac. Surg., 38(3), 326–332 (2010).
  • Badiu CC , EichingerW, BleizifferSet al.: Should root replacement with aortic valve-sparing be offered to patients with bicuspid valves or severe aortic regurgitation?Eur. J. Cardiothorac. Surg., 38(5), 515–522 (2010).
  • Luciani GB , ViscardiF, PilatiMet al.: The Ross-Yacoub procedure for aneurysmal autograft roots: a strategy to preserve autologous pulmonary valves.J. Thorac. Cardiovasc. Surg., 139(3), 536–542 (2010).
  • Fogelman R , NykanenD, SmallhornJFet al.: Endovascular stents in the pulmonary circulation clinical impact on management and medium-term follow-up.Circulation, 92(4), 881–885 (1995).
  • Bergersen L , LockJE: What is the current option of first choice for treatment of pulmonary arterial stenosis?Cardiol. Young, 16(4), 329–338 (2006).
  • van Gameren M , WitsenburgM, TakkenbergJJMet al.: Early complications of stenting in patients with congenital heart disease: a multicentre study.Eur. Heart J., 27(22), 2709–2715 (2006).
  • Bökenkamp R , BlomNAet al., De Wolf D : Intraoperative stenting of pulmonary arteries. Eur. J. Cardiothorac. Surg., 27(4), 544–547 (2005).
  • Menon SC , CettaF, DearaniJAet al.: Hybrid intraoperative pulmonary artery stent placement for congenital heart disease.Am. J. Cardiol., 102(12), 1737–1741 (2008).
  • Beghetti M , GalieN: Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension.J. Am. Coll. Cardiol., 53(9), 733–740 (2009).
  • Galie N , TorbickiA, BarstRet al.: Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology.Eur. Heart J., 25(24), 2243–2278 (2004).
  • Galiè N , RubinL, HoeperMet al.: Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial.Lancet, 371(9630), 2093–2100 (2008).
  • Vongpatanasin W , BricknerME, HillisLD, LangeRA: The Eisenmenger syndrome in adults.Ann. Intern. Med., 128(9), 745–755 (1998).
  • Duffels MGJ , VisJCet al., van Loon RLE : Effect of bosentan on exercise capacity and quality of life in adults with pulmonary arterial hypertension associated with congenital heart disease with and without Down‘s syndrome. Am. J. Cardiol., 103(9), 1309–1315 (2009).
  • Galie N , BeghettiM, GatzoulisMet al.: Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study.Circulation, 114(1), 48–54 (2006).
  • Reinhardt Z , UzunO, BholeVet al.: Sildenafil in the management of the failing Fontan Circulation.Cardiol. Young, 20(5), 522–525 (2010).
  • van Loon RLE , HoendermisES, DuffelsMGJet al.: Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist?Am. Heart J., 154(4), 776–782 (2007).
  • Tay ELW , PapaphylactouM, DillerGPet al.: Quality of life and functional capacity can be improved in patients with Eisenmenger syndrome with oral sildenafil therapy.Int. J. Cardiol. (2010) (Epub ahead of print).
  • Predescu D , ChaturvediRR, FriedbergMKet al.: Complete heart block associated with device closure of perimembranous ventricular septal defects.J. Thorac. Cardiovasc. Surg., 136(5), 1223–1228 (2008).
  • Morris C , RellerM, MenasheV: Thirty-year incidence of infective endocarditis after surgery for congenital heart defect.JAMA, 279(8), 599–603 (1998).
  • Gersony W , HayesC, DriscollDet al.: Bacterial endocarditis in patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect.Circulation, 87(Suppl. 2), I121–I126 (1993).
  • Roberts GJ : Dentists are innocent! ‘Everyday‘ bacteremia is the real culprit: a review and assessment of the evidence that dental surgical procedures are a principal cause of bacterial endocarditis in children.Pediatr. Cardiol., 20(5), 317–325 (1999).
  • Li W , SomervilleJ: Infective endocarditis in the grown-up congenital heart (GUCH) population.Eur. Heart J., 19(1), 166–173 (1998).
  • Di Fillipo FS , DelahayeF, SemiondBet al.: Current patterns of infective endocarditis in congenital heart disease.Heart, 92(10), 1490–1495 (2006).
  • Habib G , HoenB, TornosPet al.: Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC).Eur. Heart J., 30(19), 2369–2413 (2009).
  • van der Velde ET , VanderVET, VriendJWJet al.: CONCOR, an initiative towards a national registry and DNA-bank of patients with congenital heart disease in the Netherlands: rationale, design, and first results.Eur. J. Epidemiol., 20(6), 549–557 (2005).
  • Joziasse IC et al. , van de Smagt JJ, Smith K : Genes in congenital heart disease: atrioventricular valve formation. Basic Res. Cardiol., 103(3), 216–227 (2008).
  • Smith KA , JoziasseIC, ChocronSet al.: Dominant-negative ALK2 allele associates with congenital heart defects.Circulation, 119(24), 3062–3069 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.